Literature DB >> 7060330

Effects of total plasma concentration and age on tolbutamide plasma protein binding.

J Adir, A K Miller, R E Vestal.   

Abstract

Tolbutamide plasma protein binding at different total tolbutamide concentrations was determined in 44 healthy, nonsmoking, drug-free men from 23 to 87 yr old. The data showed that unbound drug increased with total tolbutamide plasma concentration and with age, but that neither the binding equilibrium constant nor the number of binding sites correlated with age. The increase in unbound fraction with age could be partially explained by the decrease in albumin concentration in elderly subjects. Results of multiple linear regression analysis indicated that, although age had a considerably greater influence than albumin concentration, total tolbutamide concentration was the most important determinant of the unbound fraction. Thus, both age and total plasma concentration may affect tolbutamide kinetics.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060330     DOI: 10.1038/clpt.1982.65

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

Review 1.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 2.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

3.  Effect of age and sex on the plasma binding of acidic and basic drugs.

Authors:  R K Verbeeck; J A Cardinal; S M Wallace
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non-insulin-dependent diabetes.

Authors:  R E Ferner; M L Antsiferov; A W Kelman; K G Alberti; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers.

Authors:  K D Wilner; M J Gardner
Journal:  Br J Clin Pharmacol       Date:  1995       Impact factor: 4.335

Review 6.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

7.  Excretion of tolbutamide metabolites in young and old subjects.

Authors:  A K Miller; J Adir; R E Vestal
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.